Nutrition News

Researchers are exploring the relationship between vitamin D, inflammation and dry eye now more than ever before.

Dietary supplementation of lutein, zeaxanthin, omega-3 fatty acids and vitamins does not increase macular pigment optical density (MPOD) in healthy individuals with a family history of age-related macular degeneration and may, therefore, not be effective as a strategy to prevent AMD, according to a study carried out in two French universities.

In 2016, Professor Christophe Baudouin and colleagues published a comprehensive paper on meibomian gland dysfunction, calling it, “the most frequent cause of dry eye disease.

LAS VEGAS – Dosing of omega-3 in patients with dry eye depends on disease severity, body mass index and diet, according to Paul M. Karpecki, OD, FAAO, here at Vision Expo West.

Age-related macular degeneration is the leading cause of blindness in the U.S. and Canada, and any scientific approach to reduce the cases of blindness should be taken seriously by clinicians.

A study based on a patient level simulation model demonstrated that the use of Age-Related Eye Disease Study supplements in patients with AREDS category 4 neovascular age-related macular degeneration in one eye would be highly cost effective in the U.K. National Health Service setting, leading to significant saving from decreased need of ranibizumab injections.

Bausch + Lomb has launched an updated formula of its nutritional supplement Ocuvite Adult 50+ to now include highly concentrated fish oils, making the tablets smaller and easier to swallow.

MacuHealth and M&S Technologies have announced a partnership to educate eye care professionals on the benefit of enriching macular pigment with nutritional supplements.

MedOp Health announced in a press release that its new MaxiVision Meso Plus Formula contains all levels of carotenoids claimed on its label.

WASHINGTON – No matter where the inflammation associated with meibomian gland dysfunction is coming from, you need to attack it at its base, Doug Devries, OD, said here at Optometry’s Meeting.